The field is rapidly moving beyond single-target GLP-1 agonism: dual and triple agonists, combining GLP-1 with receptors for GIP and/or glucagon, are designed to produce larger weight loss and beneficial metabolic effects
Disclaimer: For Research Purposes Only This content is provided strictly for research purposes and does not constitute an endorsement or recommendation for the non-laboratory application or improper handling of peptides designed for research
Proposed Mechanisms DSIP appears to work through multiple pathways: it may affect GABA-A receptors, the same inhibitory pathways targeted by common sleep medications
Many patients report a crisp surge in mental alertness, clarity, and physical stamina within 12 to 24 hours post-injection
1 2 Journal of the Academy of Nutrition and Dietetics
Whats new is the price, says Graham Simpson, M.D., a physician with Opt Health, a telemedicine clinic that offers peptides